Skip to main content

Utilization of NME

Basic Details
Date Posted
Status
Complete
Medical Product
new molecular entities (NMEs)
Description

In this report, we characterized dispensing and administration patterns of 25 New Molecular Entities (NMEs) approved from January 1, 2020, to June 30, 2020, stratified by age and sex in the Sentinel Distributed Database (SDD).

In this report, we characterized dispensing and administration patterns of 28 New Molecular Entities (NMEs) approved from July 1, 2020, to December 31, 2020, stratified by age and sex in the Sentinel Distributed Database (SDD).

Deliverables (2)
Sentinel Modular Program Report: Utilization of NME Approved 2020, Report 1 Sentinel Modular Program Report: Utilization of NME Approved 2020, Report 2
Additional Details
FDA Center
CDER
Time Period
January 1, 2020 - June 30, 2020; July 1, 2020 - December 31, 2020
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: New Molecular Entities (NMEs) & Utilization Characterization
Sentinel Drug Study: New Molecular Entities (NMEs) & Utilization Characterization
test
test 2